These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 5527291)

  • 1. [Psychological phenomenona during therapy with L-dopa. I].
    Pinto F; Venturini E
    Riv Neurobiol; 1970; 16(4):406-14. PubMed ID: 5527291
    [No Abstract]   [Full Text] [Related]  

  • 2. [Results of treatment of Parkinsonism with L-dopa].
    De Divitiis E; D'Andrea F; Signorelli CD
    Sist Nerv; 1970; 22(2):99-108. PubMed ID: 5504563
    [No Abstract]   [Full Text] [Related]  

  • 3. [L-dopa treatment of persons with parkinsonism in a hospital for geriatric rehabilitation].
    Antonini F; Baroni A; Roveyaz L
    Sist Nerv; 1970; 22(2):74-81. PubMed ID: 5504560
    [No Abstract]   [Full Text] [Related]  

  • 4. Failures of L-dopa.
    Paulson GW
    Ohio State Med J; 1973 Dec; 69(12):896-8. PubMed ID: 4769406
    [No Abstract]   [Full Text] [Related]  

  • 5. L-dopa for parkinsonism.
    Reveno WS; Bauer RB; Rosenbaum H
    Geriatrics; 1973 Jan; 28(1):86-8. PubMed ID: 4683093
    [No Abstract]   [Full Text] [Related]  

  • 6. [Longtime study on the effects of L-dopa therapy in parkinsonism].
    Fischer PA; Schneider E; Jacobi P; Maxion H
    Nervenarzt; 1973 Mar; 44(3):128-35. PubMed ID: 4572536
    [No Abstract]   [Full Text] [Related]  

  • 7. [Case reports of some mental disorders in parkinsonian patients treated with L-dopa].
    Almici GM; Sbarbaro V
    Minerva Med; 1974 Feb; 65(8):398-401. PubMed ID: 4820722
    [No Abstract]   [Full Text] [Related]  

  • 8. L-dopa treatment of parkinsonism. Clinical observations on the use of amantadine hydrochloride.
    Reveno WS; Bauer RB; Rosenbaum H
    Geriatrics; 1971 Aug; 26(8):61-70. PubMed ID: 5096462
    [No Abstract]   [Full Text] [Related]  

  • 9. A hort-term evaluation of L-dopa therapy in 34 patients with parkinsonism.
    Mones RJ; Elizan TS
    J Mt Sinai Hosp N Y; 1969; 36(6):503-15. PubMed ID: 5261089
    [No Abstract]   [Full Text] [Related]  

  • 10. [L-Dopa therapy in Parkinson's disease. A double-blind study].
    Worm-Petersen J; Dupont E; Mikkelsen B
    Ugeskr Laeger; 1971 Nov; 133(47):2321-6. PubMed ID: 4944651
    [No Abstract]   [Full Text] [Related]  

  • 11. [Psychiatric complications of L-Dopa treatment of parkinsonism].
    Refsum H
    Tidsskr Nor Laegeforen; 1973 Apr; 93(10):680-5. PubMed ID: 4755082
    [No Abstract]   [Full Text] [Related]  

  • 12. L-dopa and parkinsonism.
    Okihiro MM
    Hawaii Med J; 1971; 30(5):390-2. PubMed ID: 5160226
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of parkinsonism with L-dopa].
    Hernández Peniche J; Martínez Villar C; De León Charles C
    Rev Invest Clin; 1971; 23(2):125-32. PubMed ID: 5114336
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of parkinsonism with L-dopa].
    Chouza C; Marín C; Romero S; Gomensoro JB
    Acta Neurol Latinoam; 1970; 16(1):170-83. PubMed ID: 5538052
    [No Abstract]   [Full Text] [Related]  

  • 15. [Psychologic evaluation of amantadine treatment of parkinsonism and comparative analysis of the effects with L-dopa].
    Puca FM; Micalizzi V; Megna GF; Barbieri NF; Pigneri MT
    Acta Neurol (Napoli); 1971; 26(6):707-30. PubMed ID: 4946491
    [No Abstract]   [Full Text] [Related]  

  • 16. [Action of L-dopa in Parkinson's syndrome].
    Ucar S; Eiras J
    Rev Clin Esp; 1971 Feb; 120(3):257-62. PubMed ID: 5568474
    [No Abstract]   [Full Text] [Related]  

  • 17. [L-dopa in Parkinson's syndrome].
    Filho RM; de Karam GM
    Rev Bras Med; 1971 May; 28(5):220-31. PubMed ID: 5563096
    [No Abstract]   [Full Text] [Related]  

  • 18. [Preliminary results of the treatment with L-Dopa of 30 patients with Parkinsonism].
    Dumas R; Rahme M; Schott B
    J Med Lyon; 1971 Apr; 52(207):599-615. PubMed ID: 5136571
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of Parkinson's syndrome with L-dopa. In operated and nonoperated cases].
    Pimenta Ada M; Friguglietti DJ
    Rev Bras Med; 1971 Sep; 28(9):481-96. PubMed ID: 5139650
    [No Abstract]   [Full Text] [Related]  

  • 20. Quantitative measurements of L-dopa therapy in Parkinson's disease.
    Webster DD
    Trans Am Neurol Assoc; 1969; 94():348-50. PubMed ID: 5374483
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.